All Stories

  1. Surgical considerations for adult Graves’ disease: a narrative review of indications, perioperative challenges and postoperative outcomes

    Article • Expert Review of Endocrinology & Metabolism, May 2026, Taylor & Francis

    Daniela Gallo

  2. Graves’ orbitopathy following Alemtuzumab treatment for multiple sclerosis: a systematic review and real-world insights

    Article • Thyroid Research, December 2025, Springer Science + Business Media

    Daniela Gallo

  3. Comparison of the 2021 EUGOGO guidelines and the 2022 ATA/ETA consensus statement for the management of Graves’ orbitopathy

    Article • European Thyroid Journal, December 2025, Bioscientifica

    Daniela Gallo

  4. Impact of thyroid disorders on flow-mediated dilation: a systematic review and meta-analysis

    Article • Journal of Endocrinological Investigation, November 2025, Springer Science + Business Media

    Daniela Gallo

  5. Process to radioactive iodine treatment for Graves’ hyperthyroidism: condemned or absolved?

    Article • Journal of Endocrinological Investigation, August 2025, Springer Science + Business Media

    Daniela Gallo

  6. Natural Killer Cells in Graves’ Disease: Increased Frequency but Impaired Degranulation Ability Compared to Healthy Controls

    Article • International Journal of Molecular Sciences, January 2025, MDPI AG

    Daniela Gallo

  7. Nutritional Approach in Thyroid Disease: Reality and Myths to Dispel

    Article • January 2025, Springer Science + Business Media

    Daniela Gallo

  8. Assessment of the Correlation between Unipolar and Bipolar Depression, Calcium Levels, Thyroid Function, and Inflammatory Markers: A Pilot Prospective Study

    Article • September 2024, MDPI AG

    Daniela Gallo

  9. Autoimmune thyroid diseases

    Article • January 2024, Elsevier

    Daniela Gallo

  10. Role of regulatory T cells in pathogenesis and therapeutics of Graves’ disease and Graves’ orbitopathy

    Article • January 2024, Elsevier

    Daniela Gallo

  11. Serum thyroid hormone-binding proteins

    Article • January 2024, Elsevier

    Daniela Gallo

  12. Smoking and the thyroid

    Article • January 2024, Elsevier

    Daniela Gallo

  13. Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors

    Article • Ophthalmic Plastic and Reconstructive Surgery, December 2023, Wolters Kluwer Health

    Daniela Gallo

  14. Regulatory T Cells in the Pathogenesis of Graves’ Disease

    Article • International Journal of Molecular Sciences, November 2023, MDPI AG

    Daniela Gallo

  15. Evaluation of the Safety of Neauvia Stimulate Injectable Product in Patients with Autoimmune Thyroid Diseases Based on Histopathological Examinations and Retrospective Analysis of Medical Records

    Article • Gels, May 2023, MDPI AG

    Daniela Gallo

  16. Editorial: Immunocellular mechanisms and endocrine organs

    Article • Frontiers in Endocrinology, May 2023, Frontiers

    Daniela Gallo

  17. Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves’ disease patients during methimazole treatment

    Article • Frontiers in Endocrinology, April 2023, Frontiers

    Daniela Gallo, Giovanni Veronesi

  18. How Does Vitamin D Affect Immune Cells Crosstalk in Autoimmune Diseases?

    Article • International Journal of Molecular Sciences, February 2023, MDPI AG

    Daniela Gallo

  19. Clinical and oncological outcomes in single-stage versus staged surgery for pediatric craniopharyngiomas: a multicenter retrospective study

    Article • Journal of Endocrinological Investigation, December 2022, Springer Science + Business Media

    Daniela Gallo

  20. A potential role of human RNASET2 overexpression in the pathogenesis of Graves’ disease

    Article • Endocrine, September 2022, Springer Science + Business Media

    Daniela Gallo

  21. The Old and the New in Subacute Thyroiditis: An Integrative Review

    Article • Endocrines, July 2022, MDPI AG

    Daniela Gallo

  22. Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment

    Article • Frontiers in Endocrinology, June 2022, Frontiers

    Daniela Gallo, Giovanni Veronesi

  23. Management of Graves’ hyperthyroidism: present and future

    Article • Expert Review of Endocrinology & Metabolism, March 2022, Taylor & Francis

    Daniela Gallo

  24. SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review

    Article • Journal of Endocrinological Investigation, January 2022, Springer Science + Business Media

    Daniela Gallo

  25. SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?

    Article • Journal of Endocrinological Investigation, January 2022, Springer Science + Business Media

    Daniela Gallo

  26. Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis

    Article • Vaccines, December 2021, MDPI AG

    Daniela Gallo

  27. Paraneoplastic hyperthyroidism in hCG-secreting metastatic testicular cancer

    Article • Endocrine Abstracts, May 2021, Bioscientifica

    Daniela Gallo

  28. Vitamin D, Chronic Migraine, and Extracranial Pain: Is There a Link? Data From an Observational Study

    Article • Frontiers in Neurology, May 2021, Frontiers

    Daniela Gallo

  29. Change in newly diagnosed Graves’ disease phenotype between the twentieth and the twenty-first centuries: meta-analysis and meta-regression

    Article • Journal of Endocrinological Investigation, December 2020, Springer Science + Business Media

    Daniela Gallo, Giovanni Veronesi

  30. Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy

    Article • Frontiers in Endocrinology, November 2020, Frontiers

    Daniela Gallo

  31. Predicting the Risk of Graves Disease Relapse: Commentary on “Thyroid Peroxidase Antibody Positivity is Associated with Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease”

    Article • Endocrine Practice, September 2020, Elsevier

    Daniela Gallo

  32. Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher

    Article • Frontiers in Endocrinology, July 2020, Frontiers

    Daniela Gallo

  33. Liraglutide is an effective drug for the treatment of obesity also in real life

    Article • Journal of Endocrinological Investigation, July 2020, Springer Science + Business Media

    Daniela Gallo

  34. Negative impact of high body mass index on cetuximab-mediated cellular cytotoxicity against human colon carcinoma cells

    Article • Journal of Chemotherapy, June 2020, Taylor & Francis

    Daniela Gallo

  35. When primary hyperparathyroidism comes as good news

    Article • Endocrinology Diabetes and Metabolism Case Reports, June 2020, Bioscientifica

    Daniela Gallo

  36. Gastric Xanthomatous Hyperplastic Polyps – Just an Incidental Endoscopic Finding?

    Article • Surgical Case Reports, May 2020, Science Repository OU

    Daniela Gallo

  37. Treatment of moderate-to-severe and active Graves’ orbitopathy: a step forward from the OPTIC study

    Article • Journal of Endocrinological Investigation, April 2020, Springer Science + Business Media

    Daniela Gallo

  38. The interplay between thyroid and liver: implications for clinical practice

    Article • Journal of Endocrinological Investigation, March 2020, Springer Science + Business Media

    Daniela Gallo

  39. Oral steroid prophylaxis for Graves’ orbitopathy after radioactive iodine treatment for Graves’ disease is not only effective, but also safe

    Article • Journal of Endocrinological Investigation, October 2019, Springer Science + Business Media

    Daniela Gallo, Giovanni Veronesi

  40. Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review

    Article • Journal of Endocrinological Investigation, October 2019, Springer Science + Business Media

    Daniela Gallo

  41. Features and outcome of differentiated thyroid carcinoma associated with Graves’ disease: results of a large, retrospective, multicenter study

    Article • Journal of Endocrinological Investigation, July 2019, Springer Science + Business Media

    Daniela Gallo, Giovanni Veronesi

  42. Antithyroid drug treatment for Graves’ disease: baseline predictive models of relapse after treatment for a patient-tailored management

    Article • Journal of Endocrinological Investigation, June 2018, Springer Science + Business Media

    Giovanni Veronesi, Daniela Gallo

  43. Pre-operative evaluation of obese patients admitted for bariatric surgery: observations suggesting the introduction of a detailed screening for thyroid diseases

    Article • Endocrine Abstracts, May 2018, Bioscientifica

    Daniela Gallo

  44. Decreased levels of vitamin D may favor diabetes

    Article • Pediatric Diabetes, April 2018, Wiley

    Antonio Toniolo, Daniela Gallo

  45. Vitamin D, visceral obesity and metabolic diseases

    Article • Endocrine Connections, October 2017, Bioscientifica

    Daniela Gallo, Giovanni Veronesi

  46. Demographic and baseline characteristics of an obese population admitted for bariatric surgery in a secondary care centre

    Article • Endocrine Abstracts, May 2017, Bioscientifica

    Daniela Gallo

  47. Metabolic profile reversal after bariatric surgery

    Article • Endocrine Abstracts, May 2017, Bioscientifica

    Daniela Gallo

  48. Physical performance in newly diagnosed hypothyroidism: a pilot study

    Article • Journal of Endocrinological Investigation, April 2017, Springer Science + Business Media

    Giovanni Veronesi, Daniela Gallo

  49. The phenotype of newly diagnosed Graves’ disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study

    Article • Journal of Endocrinological Investigation, July 2016, Springer Science + Business Media

    Giovanni Veronesi, Daniela Gallo

  50. Masked hypertension in newly diagnosed hypothyroidism: a pilot study

    Article • Journal of Endocrinological Investigation, May 2016, Springer Science + Business Media

    Giovanni Veronesi, Daniela Gallo

  51. Outcome Prediction of Treatment of Graves’ Hyperthyroidism with Antithyroid Drugs

    Article • Hormone and Metabolic Research, July 2015, Thieme Publishing Group

    Professor Luigi Bartalena, Daniela Gallo

  52. Pituitary apoplexy during pregnancy: a rare, but dangerous headache

    Article • Journal of Endocrinological Investigation, June 2014, Springer Science + Business Media

    Daniela Gallo

  53. Prevalence and Natural History of Graves' Orbitopathy in a Large Series of Patients With Newly Diagnosed Graves' Hyperthyroidism Seen at a Single Center

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2013, Endocrine Society

    Giovanni Veronesi, Daniela Gallo